Hutch News

AIDS@40: Stories of hope and heroes

AIDS@40: Stories of hope and heroes

The people and the science devoted to stopping HIV
Hutch NewsMay 27, 2021
Highlights of Fred Hutch science in 2018

Highlights of Fred Hutch science in 2018

A look back at notable advances in immunotherapy, precision screening and more
Hutch NewsDecember 18, 2018
Meet Peru's HIV superhero

Meet Peru's HIV superhero

By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
Hutch NewsJanuary 22, 2018
New HIV vaccine study launched for World AIDS Day

New HIV vaccine study launched for World AIDS Day

As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Hutch NewsDecember 01, 2017
Community-building leads to record enrollment in HIV prevention study

Community-building leads to record enrollment in HIV prevention study

Fighting the stigma of HIV among communities of color takes trust — and time
Hutch NewsAugust 04, 2017
Empowering ‘millions of women’ against HIV

Empowering ‘millions of women’ against HIV

AMP study in sub-Saharan Africa tests an antibody infusion that could put protection in women’s hands
Hutch NewsOctober 21, 2016
Renewed hope at AIDS conference for halting HIV through vaccine

Renewed hope at AIDS conference for halting HIV through vaccine

At International AIDS Conference, researchers are optimistic as two new HIV vaccine trials are set to explore different approaches for protection
Hutch NewsJuly 19, 2016
Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene

Beyond immunotherapy: Xconomy forum covers breadth of Seattle’s life sciences scene

Xconomy forum highlights research in vaccines, organ transplants, big data, more
Hutch NewsMay 03, 2016
A new path to an AIDS vaccine?

A new path to an AIDS vaccine?

A ‘landmark’ clinical trial called the AMP study launches on three continents to test HIV-blocking super antibodies
Hutch NewsApril 07, 2016